149 related articles for article (PubMed ID: 12665899)
21. Effects of Clinacanthus siamensis leaf extract on influenza virus infection.
Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C
Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089
[TBL] [Abstract][Full Text] [Related]
22. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
Fu TM; Freed DC; Horton MS; Fan J; Citron MP; Joyce JG; Garsky VM; Casimiro DR; Zhao Q; Shiver JW; Liang X
Virology; 2009 Mar; 385(1):218-26. PubMed ID: 19070878
[TBL] [Abstract][Full Text] [Related]
23. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
Renegar KB; Small PA; Boykins LG; Wright PF
J Immunol; 2004 Aug; 173(3):1978-86. PubMed ID: 15265932
[TBL] [Abstract][Full Text] [Related]
24. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
[TBL] [Abstract][Full Text] [Related]
25. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
Kitikoon P; Strait EL; Thacker EL
Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
[TBL] [Abstract][Full Text] [Related]
26. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
27. Prevention and treatment of lethal influenza A virus bronchopneumonia in mice by monoclonal antibody against haemagglutinin stem region.
Lipatov AS; Gitelman AK; Smirnov YuA
Acta Virol; 1997 Dec; 41(6):337-40. PubMed ID: 9607093
[TBL] [Abstract][Full Text] [Related]
28. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities.
Yewdell J; Gerhard W
J Immunol; 1982 Jun; 128(6):2670-5. PubMed ID: 6281335
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies to influenza A virus FM1 (H1N1) proteins require individual conditions for optimal reactivity in binding assays.
Kammer K
Immunology; 1983 Apr; 48(4):799-808. PubMed ID: 6187672
[TBL] [Abstract][Full Text] [Related]
30. [Differentiated study of specific antibody populations as a possible way to increase the prognostic value of indicators of humoral immunity in influenza].
Meringova LF; Iakovleva IV; Voĭtsekhovskiĭ BL; Dukhin AI; Poliak RIa
Vestn Akad Med Nauk SSSR; 1989; (11):75-80. PubMed ID: 2623938
[TBL] [Abstract][Full Text] [Related]
31. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
[TBL] [Abstract][Full Text] [Related]
32. [Generation of human recombinant antibody Fab fragment to influenza virus from combined antibody library].
Yang G; Han F; Liang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):182-5. PubMed ID: 11436656
[TBL] [Abstract][Full Text] [Related]
33. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
34. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.
Lim AP; Chan CE; Wong SK; Chan AH; Ooi EE; Hanson BJ
Virol J; 2008 Oct; 5():130. PubMed ID: 18957074
[TBL] [Abstract][Full Text] [Related]
35. [Recombinant expression of human influenza A virus nucleocapsid protein and its antigenicity analyses].
Bao YH; Xin RL; Deng J; Wang F; Qian Y; Wu JX; Zhang T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):208-10. PubMed ID: 19031705
[TBL] [Abstract][Full Text] [Related]
36. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
37. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
[TBL] [Abstract][Full Text] [Related]
38. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
[TBL] [Abstract][Full Text] [Related]
39. Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice.
Zhou Y; Fang F; Chen J; Wang H; Chang H; Yang Z; Chen Z
Intervirology; 2008; 51(4):241-6. PubMed ID: 18812697
[TBL] [Abstract][Full Text] [Related]
40. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
